X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9393) 9393
Publication (605) 605
Book Chapter (153) 153
Dissertation (121) 121
Book Review (101) 101
Conference Proceeding (92) 92
Book / eBook (9) 9
Web Resource (6) 6
Data Set (5) 5
Magazine Article (3) 3
Government Document (2) 2
Paper (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4580) 4580
drug interactions (3418) 3418
pharmacology & pharmacy (3414) 3414
index medicus (2900) 2900
drug-drug interactions (2886) 2886
animals (2659) 2659
male (2285) 2285
drug-drug interaction (2188) 2188
pharmacokinetics (1558) 1558
female (1492) 1492
rats (1090) 1090
receptors, drug - drug effects (1049) 1049
adult (974) 974
middle aged (858) 858
metabolism (835) 835
in-vitro (715) 715
aged (643) 643
pharmacology (596) 596
dose-response relationship, drug (590) 590
drug–drug interaction (586) 586
analysis (571) 571
inhibition (559) 559
mice (546) 546
drugs (513) 513
toxicology (496) 496
drug–drug interactions (495) 495
kinetics (482) 482
p-glycoprotein (474) 474
cytochrome p450 (430) 430
in vitro techniques (424) 424
biochemistry & molecular biology (421) 421
drug interaction (410) 410
cytochrome p-450 enzyme system - metabolism (407) 407
cytochrome p-450 (394) 394
young adult (375) 375
area under curve (372) 372
drug therapy, combination (359) 359
models, biological (359) 359
pharmacology/toxicology (344) 344
research (341) 341
chemistry, multidisciplinary (338) 338
enzymes (318) 318
receptors, drug - metabolism (313) 313
drug therapy (311) 311
liver (306) 306
human liver-microsomes (300) 300
prediction (294) 294
rats, sprague-dawley (294) 294
adolescent (291) 291
administration, oral (279) 279
time factors (270) 270
pharmacy (269) 269
metabolites (266) 266
therapy (265) 265
cytochrome p-450 cyp3a - metabolism (262) 262
polypharmacy (261) 261
liver - metabolism (257) 257
cells, cultured (254) 254
chemistry, medicinal (254) 254
pharmaceutical preparations - metabolism (251) 251
cancer (247) 247
cross-over studies (247) 247
cyp3a4 (245) 245
physiological aspects (245) 245
microsomes, liver - metabolism (242) 242
complications and side effects (241) 241
pharmacodynamics (239) 239
drug design (230) 230
medicine & public health (230) 230
protein binding (230) 230
aged, 80 and over (229) 229
oncology (229) 229
safety (224) 224
biomedicine (221) 221
enzyme inhibitors - pharmacology (216) 216
expression (216) 216
article (215) 215
risk factors (215) 215
microsomes, liver - drug effects (213) 213
internal medicine (209) 209
microsomes, liver - enzymology (206) 206
drug metabolism (203) 203
induction (201) 201
binding sites (199) 199
drug synergism (196) 196
warfarin (192) 192
care and treatment (188) 188
risk (187) 187
structure-activity relationship (187) 187
cell line (186) 186
rats, wistar (186) 186
dosage and administration (184) 184
absorption (177) 177
healthy-volunteers (176) 176
hiv (176) 176
health aspects (174) 174
inhibitors (173) 173
prevalence (172) 172
ketoconazole (171) 171
liver - drug effects (171) 171
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6330) 6330
Japanese (1793) 1793
Chinese (1410) 1410
German (63) 63
French (41) 41
Russian (27) 27
Spanish (23) 23
Slovenian (9) 9
Czech (7) 7
Korean (6) 6
Portuguese (6) 6
Polish (5) 5
Hungarian (2) 2
Italian (2) 2
Bulgarian (1) 1
Norwegian (1) 1
Slovak (1) 1
Thai (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 1/2011, Volume 50, Issue 1, pp. 25 - 39
Etravirine (formerly TMC125) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) with activity against wild-type and NNRTI-resistant strains of HIV-1.... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Drug-interactions | Ribavirin, drug interactions | Antiepileptic-drugs, drug interactions | Simvastatin, drug interactions | Voriconazole, drug interactions | Dexamethasone, drug interactions | Fibric-acid-derivatives, drug interactions | Rifampicin, drug interactions | Opioid-analgesics, drug interactions | Antidepressants, drug interactions | Atorvastatin, drug interactions | Antiretrovirals, drug interactions | Anti-infectives, drug interactions | Histamine-H2-receptor-antagonists, drug interactions | Diazepam, drug interactions | Ketoconazole, drug interactions | Fluconazole, drug interactions | Hypericum, drug interactions | HMG-CoA-reductase-inhibitors, drug interactions | Oral-contraceptives, drug interactions | Sildenafil, drug interactions | Omeprazole, drug interactions | Buprenorphine, drug interactions | Rosuvastatin, drug interactions | Non-nucleoside-reverse-transcriptase-inhibitors, drug interactions | Type-5-cyclic-nucleotide- phosphodiesterase-inhibitors, drug interactions | Corticosteroids, drug interactions | Paroxetine, drug interactions | Fluoxetine, drug interactions | Rifapentine, drug interactions | Ethinylestradiolnorethisterone, drug interactions | Ranitidine, drug interactions | Etravirine, drug interactions | Antifungals, drug interactions | Digoxin, drug interactions | Warfarin, drug interactions | Methadone, drug interactions | Fluvastatin, drug interactions | Rifabutin, drug interactions | Sertraline, drug interactions | Azithromycin, drug interactions | Pharmacokinetics | Calcineurin-inhibitors, drug interactions | Itraconazole, drug interactions | Proton-pump-inhibitors, drug interactions | Clarithromycin, drug interactions | TRANSCRIPTASE INHIBITOR ETRAVIRINE | METABOLISM | EXPERIENCED HIV-1-INFECTED PATIENTS | TMC125 ETRAVIRINE | HIV-NEGATIVE VOLUNTEERS | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | HUMAN LIVER | PLACEBO-CONTROLLED TRIAL | 2 DIFFERENT FORMULATIONS | CLINICAL PHARMACOKINETICS | Reverse Transcriptase Inhibitors - adverse effects | Reverse Transcriptase Inhibitors - pharmacokinetics | Drug Interactions | Drug-Related Side Effects and Adverse Reactions | Humans | Pyridazines - pharmacokinetics | Drug Therapy, Combination | Pyridazines - adverse effects | Etravirine | Drug interactions | Physiological aspects | Dosage and administration | Research | Properties | Drug therapy | HIV infection
Journal Article
Journal Article
by Zhang, YP and Li, SP and Wang, YX and Deng, G and Cao, N and Wu, C and Ding, WZ and Wang, YW and Cheng, XM and Wang, CH
MOLECULES, ISSN 1420-3049, 04/2019, Volume 24, Issue 7, p. 1430
Harmine (HAR) is a beta-carboline alkaloid widely distributed in nature. It exhibits psychopharmacological effects of improving learning and memory. However,... 
SYSTEM | DEMENTIA | RAT | memantine | liquid chromatography-mass spectrometry | ALZHEIMERS-DISEASE | HARMALINE | BIOCHEMISTRY & MOLECULAR BIOLOGY | harmine | MODEL | CHEMISTRY, MULTIDISCIPLINARY | BETA-CARBOLINE ALKALOIDS | MEMORY | pharmacokinetics | SPECIES-DIFFERENCES | MPTP | drug-drug interaction | Alzheimer's disease | Alzheimer’s disease
Journal Article
Journal Article
Journal Article
Journal Article